Keywords: Avastin, Lucentis, Wet AMD, IVAN stidy, Novartis, Roche

Second trial finds Avastin and Lucentis similar for wet-AMD

Article | 08 May 2012

Print This

One-year results from the UK.’s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study were presented at the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in